Bevacizumab works by targeting and binding to VEGF. VEGF is crucial for the formation of new blood vessels, a process that tumors exploit to secure a constant supply of nutrients and oxygen. By inhibiting VEGF, bevacizumab effectively starves the tumor, limiting its growth and ability to metastasize.
